About this trial
Asthma is an important chronic noncommunicable disease that affects children and adults following a complex immune-mediated mechanism involving airway inflammation, bronchial hyperresponsiveness, and transient and intermittent airway obstruction. A current global empirical study, published in 2025, estimated that asthma affects about 260 million people, and it is responsible for about 455,000 deaths globally. Despite the morbidity and mortality-laden nature of asthma, the awareness and knowledge of this important condition remains low among several populations. Notably, no known multi-country intervention study has ever investigated the effectiveness, acceptability, and usability of medical TV programs in educating young persons on asthma. Therefore, this two-arm randomized control trial (RCT) aims to evaluate the impact of watching a medical TV drama on asthma among a sample of individuals (who do not have prior medical knowledge) from different cultural backgrounds and countries.
Eligibility criteria
Qualifiers
Individuals who are between 18 and 35 years of age.
Individuals who are proficient in English.
Individuals who have access to a stable internet connection, a screen-enabled device, and Netflix movie platform.
Disqualifiers
Individuals with prior formal medical education.
Individuals with a clinical history of asthma.
Individuals who do not have access toa stable internet connection, a screen-enables device, or Netflix movie platform.
Individuals who are aged below 18 years or above 35 years.
Trial design
Treatments tested in this trial
- TELEVISION DRAMA